Matthew Pompili,David A. Stradiotto,Probal Kanti Datta
申请号：
US15518895
公开号：
US20170239247A1
申请日:
2015.10.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.
